TY - JOUR
T1 - A Rapid Method for Establishing Short-Term Primary Cultures of Human Tumor Cells from Fresh Tumor Biopsies
AU - Mavligit, Giora M.
AU - Barsales, Peter B.
AU - Gutterman, Jordan U.
AU - Mackay, Bruce
AU - Hersh, Evan M.
N1 - Funding Information:
This study was supported by Grant NOI-CB-33888 from the National Cancer Institute, Bethesda, Maryland 20014. Dr. Mavligit and Gutterman are the recipients of Career Development Awards (I KO4 CA 00130 and 5 KO4 CA 71007, respectively) from the Department of Health, Education, and Welfare, National Institutes of Health, Bethesda, Maryland 20014.
PY - 1975/12
Y1 - 1975/12
N2 - A rapid method for the establishment of short-term primary cultures of human tumor cells obtained from fresh surgical biopsies is described. The method consists of the separation of the viable fraction of tumor cells by differential flotation on ficoll-hypaque density solution and its subsequent seeding into culture flasks. Tumor cell growth is established within 2–3 days. The incidence of overgrowth with fibroblasts is apparently reduced and usually delayed for 4–5 weeks, but cannot be prevented by this method. This study was supported by Grant NOI-CB-33888 from the National Cancer Institute, Bethesda, Maryland 20014. Dr. Mavligit and Gutterman are the recipients of Career Development Awards (I KO4 CA 00130 and 5 KO4 CA 71007, respectively) from the Department of Health, Education, and Welfare, National Institutes of Health, Bethesda, Maryland 20014.
AB - A rapid method for the establishment of short-term primary cultures of human tumor cells obtained from fresh surgical biopsies is described. The method consists of the separation of the viable fraction of tumor cells by differential flotation on ficoll-hypaque density solution and its subsequent seeding into culture flasks. Tumor cell growth is established within 2–3 days. The incidence of overgrowth with fibroblasts is apparently reduced and usually delayed for 4–5 weeks, but cannot be prevented by this method. This study was supported by Grant NOI-CB-33888 from the National Cancer Institute, Bethesda, Maryland 20014. Dr. Mavligit and Gutterman are the recipients of Career Development Awards (I KO4 CA 00130 and 5 KO4 CA 71007, respectively) from the Department of Health, Education, and Welfare, National Institutes of Health, Bethesda, Maryland 20014.
UR - http://www.scopus.com/inward/record.url?scp=0016604276&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016604276&partnerID=8YFLogxK
U2 - 10.3181/00379727-150-39087
DO - 10.3181/00379727-150-39087
M3 - Article
C2 - 1208579
AN - SCOPUS:0016604276
VL - 150
SP - 597
EP - 601
JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)
JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)
SN - 0037-9727
IS - 3
ER -